Table 2

Procedural and outcome variables for patients undergoing TAVI at Morriston Cardiac Centre

VariableAll
(n=387)
Less deprived
(n=296)
More deprived
(n=91)
P value
Femoral approach—n %307 (89.2)231 (88.5)74 (91.4)0.470
General anaesthesia—n %131 (38.3)102 (39.2)28 (35)0.496
Complication: MI—n %0 (0)0 (0)0 (0)
Complication—death—n %3 (0.9)3 (1.2)0 (0)
Complication—tamponade—n %5 (1.5)5 (2)0 (0)
Complication—major apical cannulation—n %0 (0)0 (0)0 (0)
Complication—major vascular injury—n %5 (1.5)4 (1.6)1 (1.2)0.798
Complication—bailout PCI—n %0 (0)0 (0)0 (0)
Complication—stroke—n %1 (0.3)1 (0.4)0 (0)
Complication—cardiogenic shock—n %3 (0.9)3 (1.2)0 (0)
Emergency valve in valve—n %0 (0)0 (0)0 (0)
Device embolisation—n %2 (0.6)2 (0.8)0 (0)
Device migration—n %2 (0.7)1 (0.5)1 (1.5)0.415
GI haemorrhage—n %0 (0)0 (0)0 (0)
Tamponade postprocedure—n %1 (0.4)1 (0.5)0 (0)
Platelet transfusion—n %3 (1.1)2 (1)1 (1.5)0.741
Blood transfusion—n %21 (7.8)17 (8.5)3 (4.5)0.279
New dialysis—n (%)30 (11.2)29 (14.6)1 (1.5)0.003
ITU stay (mean±SD)1.8±2.21.9±2.51.6±1.10.087
Total stay (mean±SD)23.2±24.521.3±21.129.6±32.70.025
In-hospital death23 (5.9)17 (5.7)6 (6.7)0.735
  • Data are split by deprivation status. P values calculated using two sample t-test with unequal variance (continuous variables) or X2 test (categorical variables)

  • ITU, intensive treatment unit; MI, myocardial infarction; PCI, percutaneous coronary intervention; TAVI, transcatheter aortic valve implantation.